Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26
Key Highlights
- ➤BVA platform operates 3x faster than predecessor
- ➤BVA platform requires 50% less sample volume
- ➤BVA platform delivers >95% measurement accuracy
- ➤Daxor showcases BVA platform at MedAxiom CV Transforum Fall '26
- ➤FDA-cleared BVA technology targets readmissions and hospital stays
Expert Statements
Michael Feldschuh, President and Chief Executive Officer of Daxor
“MedAxiom’s CV Transforum is the ideal environment to demonstrate how direct blood volume measurement transforms both clinical outcomes and health system economics”
Michael Feldschuh, President and Chief Executive Officer of Daxor
“Cardiovascular care remains one of the largest cost drivers for health systems nationwide.”
Michael Feldschuh, President and Chief Executive Officer of Daxor
“By replacing subjective surrogate measures with direct, precise data, our next-generation BVA system empowers cardiovascular programs to reduce 30-day readmissions, optimize length of stay, and achieve meaningful efficiencies under value-based care models.”
FDA-cleared BVA(™) technology delivers lab-accurate precision to optimize cardiovascular service lines, reduce 30-day readmissions, and lower cost of care.
Key Highlights: * Commercial Acceleration: Daxor showcasing its next-generation Blood Volume Analyzer (BVA) platform to executive service line leaders and cardiovascular administrators * Operational & Economic Impact: Demonstrating how direct volume measurement eliminates subjective estimation, shortens length of stay, and targets key value-based metrics in cardiac care * Executive Presence: Commercial leadership hosting platform demonstrations at the MedAxiom CV Transforum Fall '26 in Denver, CO (October 22–24, 2026) OAK RIDGE, Tenn., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced its participation at the MedAxiom Cardiovascular (CV) Transforum Fall '26 Conference, held at the Gaylord Rockies Resort & Convention Center in Denver, Colorado, from October 22–24, 2026. The CV Transforum is the nation's premier conference dedicated to cardiovascular organizational performance and health system transformation.
Get started
Create a free account to read the full story.